figshare
Browse

File(s) not publicly available

CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort

journal contribution
posted on 2023-02-16, 03:37 authored by Anadil Javaid, Sheau Wen Lok, Vanessa Wong, Sally Baron-Hay, Fran Boyle, Ian CollinsIan Collins, Katharine Cuff, Richard de Boer, Lucy Gately, Chloe Georgiou, Sally Greenberg, Bhaskar Karki, Michelle Nottage, Natalie Rainey, Javier Torres, Belinda Yeo, Bianca Devitt, Peter Gibbs, Angelyn Anton
CDK4/6 Inhibitors (CKD4/6i) in advanced hormone-receptor-positive (HR+) HER2-negative (HER2-) breast cancer: Prescribing practices and outcomes in a real-world, Australian cohort

History

Journal

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Volume

18

Pagination

129-130

ISSN

1743-7555

eISSN

1743-7563

Language

English

Author URL

Publication classification

E3 Extract of paper

Title of proceedings

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Publisher

WILEY

Usage metrics

    Research Publications

    Categories

    Keywords

    Science & TechnologyLife Sciences & BiomedicineOncology

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC